Vanda Pharmaceuticals
VNDA
VNDA
109 hedge funds and large institutions have $571M invested in Vanda Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 32 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
109
Holders Change
+23
Holders Change %
+26.74%
% of All Funds
3.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
33
Increased
32
Reduced
34
Closed
9
Calls
$56.9M
Puts
$13.2M
Net Calls
+$43.7M
Net Calls Change
+$24.8M
Top Buyers
| 1 |
PC
1
Paulson & Co
New York
|
$22.6M |
| 2 |
CCM
2
Consonance Capital Management
New York
|
$19.9M |
| 3 |
3
Fidelity Investments
Boston,
Massachusetts
|
$73.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$25.3M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$28.5M |
Top Sellers
| 1 |
1
Millennium Management
New York
|
$3.25M |
| 2 |
2
Wells Fargo
San Francisco,
California
|
$516K |
| 3 |
VM
3
VHCP Management
New York
|
$0 |
| 4 |
O
4
OrbiMed
New York
|
$7.51M |
| 5 |
BBA
5
Baker Bros. Advisors
New York
|
$72.2M |
